Chemistry and Metabolism of Lipids
Biochemistry · Topic 4
Source: NMC CBME Curriculum 2024 · Volume I · Biochemistry · Topic 4 · combined PDF page 163
Practice questions
- What limitation of conventional bulk lipid analysis motivates organelle-selective labeling approaches?
- Which sequence best describes the organelle-selective click-chemistry strategy for studying fatty-acid-derived lipids?
- Which modified fatty acids were used as metabolic inputs in the reported organelle-selective labeling approach?
- In the described labeling method, what is the role of the organelle-targeted copper-free clickable dye?
- Which set contains only cellular locations in which fatty-acid-derived lipids were visualized or profiled using the reported organelle-selective strategy?
- What additional information does a pulse-chase experiment provide in the context of fatty-acid-derived lipid labeling?
- Which lipid trafficking observation was reported in pulse-chase experiments using organelle-selective labeling?
- During the reported pulse-chase analysis, which lipid showed transient accumulation within mitochondria?
- Which finding was reported about the relative distribution of fatty-acid-derived lipids among organelles?
- Why is fatty-acid composition of membrane lipids of interest when comparing organelles?
- Which analytical methods are described for downstream analysis of samples prepared with the organelle-selective labeling protocol?
- Which statement best reflects the supplied review's account of fatty acids in T-cell biology?
- How was the crosslinked ionizable lipid C12-2aN designed according to the supplied study?
- Which combination of functions was attributed to C12-2aN-containing lipid nanoparticles in the supplied study?
- Which signaling pathway was linked to the glycolytic stimulation reported with C12-2aN lipid nanoparticles?
- Which experimental models were used to evaluate vaccine applications of the C12-2aN lipid nanoparticle?
- Compared with control lipid nanoparticles without the crosslinker, what outcome was reported for C12-2aN-containing nanoparticles in the described vaccine models?
- Against which comparator did the supplied C12-2aN study report reduced off-target delivery and lower immunogenicity?